Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksITE Group Share News (ITE)

  • There is currently no data for ITE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up

Mon, 11th May 2015 15:36

RBS: Credit Suisse reiterates underperform and 320p target.GlaxoSmithKline: Deutsche reiterates hold and lowers target to 1,540p from 1,600p.HSBC: Exane BNP reiterates underperform and 600p target.Lloyds: Credit Suisse reiterates neutral and 72p target.Sage Group: Goldman Sachs reiterates neutral and ups target to 565p from 540p.Aberdeen Asset Management: Societe Generale downgrades to hold with a 485p target.ITE Group: Westhouse Securities reiterates neutral and raises target to 199p from 170p.Antofagasta: RBC downgrades to neutral with 800p target.Unilever: Panmure Gordon reiterates hold and keeps target at 2,895p.Bodycote: RBC reiterates buy.
More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.